France High-Intensity Focused Ultrasound Market

France High-Intensity Focused Ultrasound Market Insights Forecasts to 2035

• France High-Intensity Focused Ultrasound Market Size 2024: USD 47.1 Mn
• France High-Intensity Focused Ultrasound Market Size 2035:  USD 99.2 Mn
• France High-Intensity Focused Ultrasound Market CAGR 2024: 7.01%
• France High-Intensity Focused Ultrasound Market Segments: Product, Application, and Distribution Channel

The France high-intensity focused ultrasound market involves medical technologies and clinical applications that utilize focused ultrasound energy to noninvasively remove or change the function of the targeted tissues without the need for incisions. In France, HIFU is being implemented in various fields such as oncology (prostate cancer, liver tumors, and uterine fibroids), neurology, and aesthetic treatments, and it is being driven by the presence of advanced imaging, a well-developed hospital network, and an increasing trend of minimally invasive, outpatient-based procedures.

 

France’s adoption of high-intensity focused ultrasound is closely linked to population health needs and disease burden. Cancer continues to be a worry that takes the lead among the factors causing diseases in France. More than 430,000 new cancer cases are recorded each year. The cases of prostate, liver, and gynecological cancers are among the most common, and these are the areas where high-intensity focused ultrasound is increasingly being used. Besides that, fibroids in the uterus affect close to 30-40% of the female population of reproductive age, and the occurrence of neurological diseases like essential tremor and Parkinson's disease is increasing as the population gets older. The above-mentioned conditions show the increased demand for non-invasive treatments that save the organ. Therefore, the France HIFU market becomes more and more relevant.

 

The French high-intensity focused ultrasound market's future looks bright with several promising opportunities. These are mainly driven by the demand for minimally invasive therapies, shorter hospital stays, and reduced healthcare costs. The efficient public healthcare system in France, together with a vibrant clinical research ecosystem, is a major support for the HIFU implementation that takes place through hospital modernization and innovation programs. Besides that, government-sponsored research initiatives, medical imaging and oncology innovation funding, and support from various institutions like INSERM and public university hospitals are some of the factors that indirectly facilitate the development and clinical validation of HIFU technology and strengthen its long-term role in France’s therapeutic landscape.

 

Market Dynamics of the France High-Intensity Focused Ultrasound Market:

The France high-intensity focused ultrasound market is driven by the increasing incidences of cancers and uterine fibroids, the patients' choice of non-invasive treatments, the recovery period of less than a day, and the decreasing number of hospitals stays. The development of technologies in image-guided high-intensity focused ultrasound and easy accessibility due to France’s healthcare and research ecosystem are the two main factors that support the further spread of the device.

 

The French high-intensity focused ultrasound market is restrained by the expensive HIFU systems, scarcity of specialized treatment centers, and the requirement of skilled clinicians. Moreover, payer constraints, tough regulatory approvals, and limited clinical indications are some of the factors that hinder the rapid adoption of high-intensity focused ultrasound throughout France.

 

The market for High-Intensity Focused Ultrasound in France offers good prospects for the future as its use is maintained in hospitals, nursing homes, and places with a high risk of infection, where the prevention of infection is the primary requirement. An increase in attention to health preparedness, emergency stockpiling, and local production are the factors that is sustaining the demand. Besides this, the invention of environmentally friendly, biodegradable, and higher-filtration disposable masks, supported by government health and research initiatives, is likely to become a leading factor for the market to evolve in a positive and sustainable way.

 

Market Segmentation

The France High-Intensity Focused Ultrasound Market share is classified into application and end use.

 

By Application:

The France high-intensity focused ultrasound market is divided by application into uterine fibroids, prostate cancer, essential tremor, dermatology, breast cancer, glaucoma, back pain, facetogenic, and other. Among these, the dermatology segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The dermatology segment dominates because of rising demand for non-invasive aesthetic and skin-tightening procedures, a growing aging population, increasing awareness of cosmetic treatments, minimal recovery time, and the widespread adoption of HIFU devices across dermatology and aesthetic clinics in France.

 

By End Use:

The France high-intensity focused ultrasound market is divided by end use into hospitals and imaging centers. Among these, the hospitals segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The hospital segment’s dominance is due to the availability of advanced medical infrastructure, higher adoption of innovative non-invasive treatment technologies, the presence of skilled specialists, and the growing number of HIFU procedures for oncology, neurology, and gynecology performed in hospital settings.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organisations/companies involved within the France high-intensity focused ultrasound market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

Top Key Companies in France High-Intensity Focused Ultrasound Market:

• Elekta AB
• Insightec Ltd.
• SonaCare Medical
• Edap TMS SA
• Theraclion SA
• FUS Instruments Inc.
• Lantheus Holdings, Inc.
• Canon Medical Systems Corporation
• Siemens Healthineers AG
• GE HealthCare Technologies Inc.
• Others

 

Recent Developments in France High-Intensity Focused Ultrasound Market:

• In September 2025, EDAP TMS’s Focal One Robotic high-intensity focused ultrasound system for prostate cancer received reimbursement approval from France’s Ministry of Health, expanding access to this non-invasive therapy under the national health system.

 

• In October 2024, EDAP TMS announced the first patients treated in a Phase I/II study of its Focal One Robotic high-intensity focused ultrasound system for benign prostatic hyperplasia (BPH) at leading French centers, reflecting development into new therapeutic areas.

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at the France, regional, and country levels from 2020 to 2035. Decisions Advisors has segmented the France High-Intensity Focused Ultrasound market based on the below-mentioned segments:

 

France High-Intensity Focused Ultrasound Market, By Application 

• Uterine Fibroids
• Prostate Cancer
• Essential Tremor
• Dermatology
• Breast Cancer
• Glaucoma
• Back Pain
• Facetogenic
• Other

 

France High-Intensity Focused Ultrasound Market, By End Use 

• Hospitals
• Imaging Centers

 

FAQ

1. What is the France high-intensity focused ultrasound market size in 2024?

The France high-intensity focused ultrasound market size was estimated at USD 47.1 million in 2024.

 

2. What is the projected market size of the France high-intensity focused ultrasound market by 2035?

The France high-intensity focused ultrasound market size is expected to reach USD 99.2 million by 2035.

 

3. What is the CAGR of the France high-intensity focused ultrasound market?

The France high-intensity focused ultrasound market size is expected to grow at a CAGR of around 7.01% from 2024 to 2035.

 

4. What are the key growth drivers of the France high-intensity focused ultrasound market?

The increasing incidence of cancers and uterine fibroids, the patients' choice of non-invasive treatments. The development of technologies in image-guided high-intensity focused ultrasound and easy accessibility due to France’s healthcare and research ecosystem are the main factors that support the further spread of the device.

 

5. Which application segment dominated the market in 2024?

The dermatology segment dominated the market in 2024.

 

6. What segments are covered in the France high-intensity focused ultrasound market report?

The France high-intensity focused ultrasound market is segmented on the basis of application and end use.